During Wednesday's Lightning Round segment of Mad Money one caller asked Jim Cramer about Amarin Corp. (AMRN) : "This is speculative and should only be bought as a spec," he replied about the biopharma company that develops and markets medicines for cardiovascular disease.
More from Investing
Just look at Snowflake, the ARKK and compare to the S&P 500 and Dow.
A trader needs to go where they have comfort, especially if buying shares.
Roll up your sleeve and know this might hurt a bit: The charts of TDOC show prices are pointed ... lower.
Here's a play in an exchange-traded fund for gold.